STOCK TITAN
  1. Home
  2. Financials
  3. GRVE

Groove Botanical Financials

GRVE
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE March

This page shows Groove Botanical (GRVE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GRVE FY2025

Balance-sheet erosion dominates as liabilities compound while cash and other current assets remain only $2K to $5K.

From FY2023 to FY2025, total liabilities rose from $443K to $1.1M even as cash and equivalents stayed between $2K and $5K, so the company added obligations without building a liquid buffer. FY2025’s small asset rebound to $5K did not change that structure because current liabilities still outweighed current assets by about $1.1M.

With negative equity of -$1.1M and a current ratio of 0.0041x in FY2025, the balance sheet offers almost no operating cushion. Compared with FY2024, liabilities increased by about $352K while cash was essentially unchanged, so the gap widened rather than healed.

Some figures from recent filings were inconsistent and were omitted from this summary.

Generated by Rhea from SEC filings [ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Groove Botanical's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
N/A
EPS (Diluted)
$-0.01
YoY+0.0%

Groove Botanical earned $-0.01 per diluted share (EPS) in fiscal year 2026. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$2K
YoY-26.4%
5Y CAGR-57.5%
10Y CAGR-41.3%

Groove Botanical held $2K in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
60M
YoY+0.0%

Groove Botanical had 60M shares outstanding in fiscal year 2026. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

GRVE Income Statement

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A $16K-2.9% $17K N/A N/A $17K-5.9% $18K N/A
Operating Income N/A N/A -$32K N/A N/A N/A -$30K N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A -$32K N/A N/A N/A -$30K N/A
EPS (Diluted) N/A $0.00 $0.00 $0.00 N/A $0.00 $0.00 $0.00

GRVE Balance Sheet

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Total Assets $4K-29.2% $6K-23.3% $8K+121.5% $4K-18.5% $5K-4.5% $5K-57.5% $11K+264.3% $3K
Current Assets $4K-29.2% $6K-23.3% $8K+121.5% $4K-18.5% $5K-4.5% $5K-57.5% $11K+264.3% $3K
Cash & Equivalents $2K+0.5% $1K+0.1% $1K-45.5% $3K+34.0% $2K+63.2% $1K-79.6% $6K+132.5% $3K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.5M+6.4% $1.4M+6.7% $1.3M+7.6% $1.2M+8.3% $1.1M+8.3% $1.0M+8.6% $947K+10.8% $855K
Current Liabilities $1.5M+6.4% $1.4M+6.7% $1.3M+7.6% $1.2M+8.3% $1.1M+8.3% $1.0M+8.6% $947K+10.8% $855K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$1.5M-6.5% -$1.4M-6.9% -$1.3M-7.2% -$1.2M-8.4% -$1.1M-8.4% -$1.0M-9.4% -$936K-9.9% -$852K
Retained Earnings -$35.6M-0.3% -$35.5M-0.3% -$35.4M-0.2% -$35.3M-0.3% -$35.2M-0.2% -$35.1M-0.3% -$35.0M-0.2% -$34.9M

GRVE Cash Flow Statement

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Operating Cash Flow -$16K+20.0% -$20K+44.3% -$36K N/A -$18K N/A -$43K N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $16K-20.0% $20K-42.3% $35K N/A $19K-10.0% $21K-54.6% $46K N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

GRVE Financial Ratios

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A -396.7% N/A N/A N/A -268.2% N/A
Current Ratio 0.000.0 0.000.0 0.010.0 0.000.0 0.000.0 0.000.0 0.010.0 0.00
Debt-to-Equity N/A N/A N/A N/A N/A N/A N/A N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$1.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Orpheum Ppty Inc PLFF
$270K
New Frontier Energy Inc NFEI
$383K
Mondial Ventu MNVN
$198K
Reostar Energy REOS
$883K
Quest Oil QOIL
$150K

Frequently Asked Questions

Groove Botanical (GRVE) reported diluted earnings per share of $-0.01 for fiscal year 2026. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Groove Botanical (GRVE) had $4K in total assets as of fiscal year 2026, including both current and long-term assets.

Groove Botanical (GRVE) had 60M shares outstanding as of fiscal year 2026.

Groove Botanical (GRVE) had a current ratio of 0.00 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Groove Botanical (GRVE) has negative shareholder equity of -$1.5M as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top